Actavis-Forest Labs is play on changes in health care
February 18, 2014 at 09:06 AM EST
Actavis is buying rival drug maker Forest Labs, in which Carl Icahn is a large shareholder.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.